Merto, Irish .
HRN: 25-69-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2024
08/16/2024
IV
1.5
Q8 For 4 Doses
Surgical Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes